Abstract
Introduction Anti-neoplastic agents constitute a significant workplace hazard for health professionals in the hospital environment [1, 2] . Such hazardous drugs, used in the treatment of cancer, have been associated with many adverse health effects following employee acute and/or chronic cumulative exposure. Cytotoxic drugs have been particularly associated with reproductive toxicity as documented by several scientific publications in the international literature [3] [4] [5] . However, such reported reproductive toxicity was linked to higher levels of workers' exposure to such drugs, usually observed in past decades [usually at the level of milligrams per milliliter (mg/mL) or (mg/cm In the US, between 2000-2005, the closed-system drug transfer device (CSTD) was introduced, and a study of environmental assessment was conducted in 22 hospitals. When standard drug delivery devices were used, the levels of contamination with positive wipe samples were 78%, 54% and 33% for Cyclophosphamide, Ifosfamide and 5-fluorouracil, respectively. With the introduction of the closed-system drug transfer device, there was a significant decrease in the levels of contamination to 68%, 45% and 20%, respectively [22] . Several other studies have shown significant reduction in the levels of occupational and environmental contamination as well as exposure to hazardous drugs following the implementation of a CSDT device [23] [24] [25] [26] [27] .
In Cyprus, there has been no previous study evaluating the potential contamination of hospital environments with hazardous drugs in the oncology units. The objective of our study was to assess the potential workplace contamination of the main oncology center of Cyprus with three most frequently used cytotoxic drugs, namely Cyclophospamide, Ifosphamide and 5-fluorouracil. In addition, we conducted a follow-up assessment study evaluating potential contamination with a number of other cytotoxic drugs three years later.
Methods

Hospital setting
An environmental contamination assessment was conducted at the Bank of Cyprus Oncology environmental assessments we were able to introduce the use of a closed system drug transfer device (CSTD) in our Center.
Wipe sample collection
Wipe samples were taken from 42 workplace surfaces including two pairs of gloves for the initial assessment, while in the follow-up assessment, a total of 10 samples were obtained. 
Results
The results of the initial environmental assessment analyses of the wipe samples are presented in Table 1 . The study findings on the initial assessment show contamination with cyclophosphamide on the work surface inside the isolator as expected (biological safety cabinet), on an office phone at the daycare unit, and on the front of the bench in the central pharmacy. surface of the bag. Except for the work space inside the isolator and the IV bag, the levels of contamination were very low. The two pair of gloves examined were not found to be contaminated with 5-fluorouracil. Overall, only 11.9% of the samples were tested positive for any of the three cytotoxics drugs evaluated.
The results of the follow-up assessment are presented in Table 2 . The follow-up assessment included a total of 12 different medications on 10 environmental samples. Based on the total number of samples multiplied by the total number of drugs tested, we found 18 positive samples with a percentage of contamination at 15% of the total samples tested. The Lid of cytotoxic waste container tested positive for contamination with 5-FU, while the floor area under the infusion stand at the daycare unit tested positive for Gemcitabine, Cyclophospamide, Docetaxel and Paclitaxel.
Discussion
The results of both environmental assessments showed quite low and similar levels of contamination in the Oncology Center of Cyprus. In the initial assessment, the contamination with cyclophosphamide or ifosphamide was detected mainly at the daycare unit and to a lesser extent in the central pharmacy and patient wards. Spread of contamination was not observed. The contamination with cyclophosphamide in the space inside the isolator, was expected to be relatively high, however the levels of contamination on the other positive samples were very low.
Contamination with 5-fluorouracil was not found in the environment. This may probably be attributed to a higher detection limit for the analysis of 5-fluorouracil compared to cyclophosphamide and ifosphamide. Overall the percentage of positive samples was much lower compared to other international scientific reports [16-20, 28, 29, 32, 33] . Low levels of contamination were also observed on the follow-up assessment conducted three years later. The difference between the two assessments is not significant (12% vs 15%) and could most likely attributed to the small number of samples used in the second assessment and the much bigger number of drugs implicated in the testing. We believe that the two assessments in general provide a similar picture of the low level contamination in our center. Except from the contamination detected in the clean room isolator and the floor underneath it, which was expected, only two other samples tested positive (the lid of cytotoxic waste container and the floor area under the infusion stand at the daycare). A sample obtained from a telephone on Ward B was negative for contamination on the follow-up assessment, compared to the wipe sample from a telephone in an office room that tested positive for contamination on the first assessment. The initial result was most likely related to unsafe practices of health professionals.
We believe that the low overall contamination levels with hazardous drugs seen in our study, may Some limitations of our study need to be acknowledged. Although this is the first study conducted in an oncology hospital in Cyprus, we lack reference data from other local hospitals in order to perform useful comparisons. In addition, due to cost limitations, we have used a relatively small number of environmental samples however we believe that the number is sufficient to obtain a comprehensive evaluation given the relatively small size of the Oncology Center. Our study was only focused on the environmental assessment for cytotoxic drugs. Nevertheless, it could have benefited from a parallel biological monitoring study to assess potential occupational exposure among health professionals. In conclusion, this is the first study conducted in Cyprus examining the potential environmental contamination with cytotoxic drugs in an oncology hospital setting. Our results show a relatively low level of contamination compared to a number of similar studies around the world. The outcome of our study in both assessments as well as the relatively low levels of environmental contamination with hazardous drugs could be attributed to a number of workplace practices including the use of a specifically designed isolator unit with biological safety cabinets externally vented through a separate ventilation system for the whole isolator unit. Furthermore, the employees involved in the drug preparation processes are highly trained and also receive annual refresher courses. The maintenance of a continuous monitoring system for dilution procedures run by trained pharmacy personnel could also play a role along with the adoption of the European Oncology Pharmacy protocol for monitoring spillages in the workplace. In addition to the above measure, between the two assessments, we had introduced the closed system drug transfer device (CSTD) in our Center. Finally, we believe that the cleaning protocols followed including a daily routine cleaning of the isolator system are contributing to the low contamination levels found. The slightly higher percentage of the positive samples in the second assessment may reflect the smaller number of samples obtained and the much larger number of medications tested. We believe that the above combination of workplace control measures may constitute a good practice that could be followed by other centers around the world in order to lower potential contamination levels and reduce associated exposure of health professionals to hazardous drugs in the workplace. 
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